Gene: ADAMTS6
Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 6provided by HGNC
Gene Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. Expression of this gene may be regulated by the cytokine TNF-alpha. [provided by RefSeq, Mar 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31128 | ADAMTS6 Knockout cell line (HeLa) | Human | ADAMTS6 | 1:3~1:6 | Negative | Online Inquiry |
ADAMTS6 Gene Knockout Cell Lines are specialized cellular models engineered to silence the expression of the ADAMTS6 gene, which encodes a member of the ADAMTS (A Disintegrin And Metalloproteinase with Thrombospondin Motifs) family. These cell lines serve as invaluable tools for examining the biological functions of the ADAMTS6 protein in various physiological and pathological processes, particularly those associated with extracellular matrix remodeling and cellular communication.
The key functions of these knockout cell lines include the ability to elucidate the role of ADAMTS6 in matrix degradation, angiogenesis, and tissue homeostasis. By abrogating the gene’s expression, researchers can investigate the downstream effects on cellular behavior and signaling pathways that are vital in various diseases, including cancer, arthritis, and cardiovascular disorders. The mechanisms of action involve intricate interactions with other matrix components and signaling molecules, allowing scientists to gain insights into disease mechanisms and identify potential therapeutic targets.
In research and clinical settings, ADAMTS6 Gene Knockout Cell Lines hold significant scientific importance. They facilitate the understanding of disease models in regenerative medicine, drug discovery, and personalized medicine. Their ability to recapitulate in vivo-like genetic alterations makes them particularly valuable in preclinical trials and translational research, where robust models are essential for testing novel therapies.
Compared to alternative models, such as wild-type cell lines or those with only partial knockdowns, ADAMTS6 knockout lines offer a more complete disruption of gene function, providing clearer and more consistent experimental outcomes. This specificity minimizes off-target effects and contributes to higher confidence in the data generated.
For researchers and clinicians alike, the value of ADAMTS6 Gene Knockout Cell Lines is rooted in their capacity to enhance experimental precision and reproducibility, aiding in the identification and validation of therapeutic interventions. By providing critical insights into the roles of matrix metalloproteinases, these cell lines pave the way for advancements in biomedical research.
Our company is dedicated to the advancement of biological research through the development and offering of high-quality, scientifically relevant products. With expertise in genetic engineering and a commitment to innovation, we provide researchers with the tools necessary to push the boundaries of knowledge in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.